• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Omega-3-acid ethyl esters - Key patent, SPC, and data exclusivity expiry (44 country coverage) Product Image

Omega-3-acid ethyl esters - Key patent, SPC, and data exclusivity expiry (44 country coverage)

  • Published: July 2014
  • Genericsweb Pty Ltd – Ark Patent Intelligence

Pipeline Selector helps you avoid hours of painstaking research by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 44 countries (7 country coverage also available), regulatory issues and key players.

This Pipeline Selector report covers Omega-3-acid ethyl esters
Omega-3-acid ethyl esters indications: Adjuvant therapy for secondary prevention in post-myocardial infarction; management of hypertriglyceridaemia and mixed lipoprotein disorders.
Omega-3-acid ethyl esters innovator: Solvay (Omacor); Reliant (Lovaza, Omacor); Pronova (Omacor); Ferrer (Omacor)

Examples of information found in this online report include:
- Includes key patent publications for 44 countries (see list below)
- Contains SPC protection for every EU state plus patent term extensions in other countries
- Data exclusivity calculated on a country by country basis
- Summary of dosage forms, strengths, indications and active ingredient forms of the brand product
- DMF & Paragraph IV filings
- Litigation alerts
- Marketing authorisation holders in selected territories
- Patent risk analysis via READ MORE >

Solvay (Omacor); Reliant (Lovaza, Omacor); Pronova (Omacor); Ferrer (Omacor)

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos